Lichen planus and its management
In a recent letter to The Journal Christine Clark stated that pharmacists should play a major role in the management of both long- and short-term skin conditions but that research is needed to identify the types of dermatological problems commonly presented.
In this article she describes lichen planus and how pharmacists can support sufferers
Lichen planus (also known as lichen ruber or lichen ruber planus) — a non infectious condition involving the skin or mucous membranes — affects up to 2 per cent of people. Although it is less well known than psoriasis and eczema, the impact of lichen planus can be significant.
For example, it has been shown that the condition has a similar impact on the patient’s quality of life to that of psoriasis and awareness of the condition and the measures that can be used to ameliorate it is important for primary care health professionals
To read the full article download the attached PDF (320K)
Christine Clark, PhD, FRPharmS, is a medical writer and chairman of the Skin Care Campaign
An article by Chuang T-Y, Stitle L. Lichen planus gives further information on histological findings and doses of third-line agents used. Further details on oral lichen planus are also available at this site, in an article authored by Sugerman P and Porter SR.
Chan ESY, Thornhill M, Zakrzewska JJM. Interventions for treating oral lichen planus. Cochrane Database of Systematic Reviews 1999, Issue 2. Art. No.: CD001168.
European Association of Oral Medicine:Oral lichen planus (PDF 260K)
Citation: The Pharmaceutical Journal URI: 11013739
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com